Product · #22 of 27 · perimenopause
Wile Perimenopause Support
Capsule from Wile, made by Wile, Inc.. Daily serving: 2 capsules.
Last updated · Price and ratings checked Nov 19, 2026
In short: Wile Perimenopause Support scores 44.4/100 in our ranking (#22 of 27). It costs $1.00 a day at the regular price. Evidence: chaste tree, alfalfa, fennel: weak evidence; best ingredient grade C (Ashwagandha). No NSF registry listing was confirmed.
Pros
- None stood out.
Cons
- No NSF registry listing confirmed.
- Evidence: chaste tree, alfalfa, fennel: weak evidence.
Flags
None found
Score breakdown
Full label: what's in it
| Ingredient (as labeled) | Per day | Evidence page |
|---|---|---|
| Alfalfa (aerial) | 300 mg | Not in our evidence library |
| Fennel seed | 300 mg | Not in our evidence library |
| Chaste tree fruit extract (Vitex) | 200 mg | Vitex (chasteberry) C- |
| Ashwagandha root & leaf extract | 130 mg | Ashwagandha C |
| Kudzu root extract | 25 mg | Not in our evidence library |
Label from the official product image.
Evidence
Our evidence score: 14/40, because: chaste tree, alfalfa, fennel: weak evidence.
Product-level research: we found no published trial of this exact product, so its evidence comes from studies of its ingredients.
Ingredient evidence
- Vitex (chasteberry) C- (200 mg here)
Vitex (chasteberry) has better evidence for menstrual-cycle comfort than for menopause. The largest menopause trial (100 women, combined with St John's wort) found no benefit over placebo. The Menopause Society 2023: Not recommended (Level II). - Ashwagandha C (130 mg here)
Ashwagandha root extract has been studied for occasional stress, sleep quality and common symptoms in perimenopause and menopause* in a few small placebo-controlled trials, all run in India. The Menopause Society 2023: Not assessed.
Studies
Studies on its ingredients (5)
-
Hypericum perforatum with Vitex agnus-castus in menopausal symptoms: a randomized, controlled trial.
100 Australian women took a St John's wort + chasteberry combination or placebo for 16 weeks. It did not beat placebo – the largest, most rigorous vitex trial.
- Who
- 100 women
- Dose
- St John's wort + Vitex combination
- Duration
- 16 weeks
- Result
- No difference vs placebo for hot flushes, Greene scale or depression.
- Funding
- Academic (Australia). Independent / academic
-
Comparison of Vitex agnus-castus Extracts with Placebo in Reducing Menopausal Symptoms: A Randomized Double-Blind Study.
52 Iranian women took chasteberry or placebo for 8 weeks; symptom questionnaires improved more with vitex. Small and questionnaire-based.
- Who
- 52 women (Iran)
- Dose
- Vitex agnus-castus extract
- Duration
- 8 weeks
- Result
- Total menopausal, anxiety and vasomotor scores lower vs placebo.
- Funding
- No conflicts reported. Independent / academic
-
Effect of an ashwagandha (Withania Somnifera) root extract on climacteric symptoms in women during perimenopause: A randomized, double-blind, placebo-controlled study.
100 Indian women in perimenopause took ashwagandha root extract (300 mg twice a day) or placebo for 8 weeks. Menopause symptoms and quality of life improved more with ashwagandha, and hormone levels shifted. The study was short and not yet repeated outside India.
- Who
- 100 perimenopausal women (91 completed)
- Dose
- ashwagandha root extract 300 mg twice daily
- Duration
- 8 weeks
- Result
- Total MRS and MENQoL improved vs placebo; estradiol up, FSH/LH down.
- Funding
- Not stated in abstract; Indian investigators (ingredient-supplier funding typical but not verified). Funding not stated
-
A prospective, randomized, double-blind, placebo-controlled study on efficacy and safety of Ashwagandha root extract (Withania somnifera) for managing menopausal symptoms in women.
60 Indian women took ashwagandha root extract or placebo for 8 weeks; symptoms, hot flashes and stress improved more with ashwagandha. Small and short.
- Who
- 60 women aged 45–55
- Dose
- ashwagandha root extract
- Duration
- 56 days
- Result
- MRS, hot-flash events and stress scores improved vs placebo.
- Funding
- Authors declared no conflicts. Independent / academic
-
Effects of Withania somnifera root extract on sleep quality, body composition, and menopausal symptoms in postmenopausal women: a randomized, double-blind, placebo-controlled trial.
66 Indian postmenopausal women took ashwagandha 600 mg a day or placebo for 12 weeks; sleep and menopause symptoms improved more with ashwagandha.
- Who
- 66 postmenopausal women (63 completed)
- Dose
- ashwagandha root extract 600 mg/day
- Duration
- 12 weeks
- Result
- Better sleep quality (PSQI -5.2 vs -0.8), menopause symptoms and body fat vs placebo; no BMD change.
- Funding
- No conflicts reported. Independent / academic
The Menopause Society's 2023 statement is in the study library.
Price
| Regular one-time price | $29.99 (60 units, 30 days at label dose) |
|---|---|
| Cost per day | $1.00 |
| Subscription | $25.49 (15% off) |
| Price notes | Amazon listing B09P2CJ85M $19.99 (possibly older formula); newer Amazon listing B0HM5KD3ZT $29.99 |
| In stock when checked | Yes |
| Checked | Nov 19, 2026 |
Ratings
Amazon: ★ 4.4 from 139 ratings on Amazon (checked Nov 19, 2026)
Star ratings reflect buyer satisfaction, not clinical effect.
Certifications and claims
Verified in a public registry
- No registry listing found.
Claims made by the brand
- “vegan” Brand claim
- “non-GMO” Brand claim
- “soy-free” Brand claim
- “plant-derived” Brand claim
- “no artificial ingredients” Brand claim
Registry check: NSF/ANSI 173: not checked by name
Who's behind it
| Brand | Wile |
|---|---|
| Owner / company | Wile, Inc. (wilewomen.com), venture-backed (seed ~$3M reported). |
| Founders | Not stated on the pages we read. |
| Where it's made | Made in USA (Amazon brand claim). Brand claim |
| Medical advisors named |
|
| Source | wilewomen.com |
Flags & safety
Legal, regulatory and quality flags
No lawsuits, regulator actions or watchdog complaints found in our search for this product or brand.
Ingredient safety notes
- Vitex (chasteberry): Few AEs; avoid with dopaminergic drugs/hormonal contraception (general caution).
- Ashwagandha: Rare liver-injury case reports exist in the literature (not reviewed here); avoid in pregnancy and with thyroid medication — standard cautions (not verified here). Trials reported raised estradiol, lower FSH/LH. Unverified
Sources
Talk to a clinician first
The Menopause Society's 2023 nonhormone position statement does not recommend any dietary supplement or herbal remedy for hot flashes, because the research is limited or mixed. Hormone therapy is an option for many women, and the statement lists non-hormonal options with evidence behind them: CBT, clinical hypnosis, SSRIs/SNRIs, gabapentin, fezolinetant (Level I), oxybutynin (I–II), weight loss, stellate ganglion block (II–III).
If hot flashes, night sweats, sleep or mood are affecting your life, talk to a clinician first. If you still want to try a supplement, the rankings below show what is actually in each one, what the research found, and who is behind it. Sources: position statement (PDF) · PubMed.
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Solynes does not sell supplements; descriptions summarize published research and are not medical advice.